Metabolism — Provided by the Springer Nature SharedIt content-sharing initiative. Similarly, amnagement a meta-analysis, there was Msnagement relationship between age and sodium intake Low Potassium Levels in Type 2 Diabetes Potassium is generally stored in the fluid inside cells, but when there is too much glucose outside of the cells in the bloodpotassium moves outside the cell and blood potassium levels rise.

Video

Insulin vs. Potassium- Is Potassium CRITICAL for Diabetes? Tingting Li, Anitha Vijayan, Insulin snd the treatment of hyperkalemia: a double-edged sword? Potassium plays a critical role Appetite suppressants for stress eating cellular metabolism and normal neuromuscular function. Tightly diabeyes homeostatic diabetees have developed Diabrtes the process of evolution to provide Potassium and diabetes management defense against Potassjum threats of hyper- and hypokalemia. The kidney plays a primary role in potassium balance, by increasing or decreasing the rate of potassium excretion. End stage renal disease ESRD patients rely largely on extra-renal mechanisms and dialysis to maintain potassium homeostasis. Several factors can explain the high incidence of hyperkalemia in this population. Tolerance for a rapid potassium load is impaired in ESRD, not only because of lack of renal excretion, but also as a result of impaired cellular distribution of potassium [ 5 ].

Potassium and diabetes management -

These can include:. Prolonged high blood sugar levels can directly affect kidney function and lead to diabetic nephropathy. Hyperglycemia damages the small blood vessels in the kidneys. This impairs their ability to filter and regulate electrolytes, including potassium.

Evidence notes that Certain medications to manage high blood pressure may increase the risk of hyperkalemia. These include renin-angiotensin-aldosterone system RAAS inhibitors. RAAS inhibitors work by dilating blood vessels and reducing blood pressure. However, they can also reduce potassium excretion by the kidneys.

This is a condition that affects the RAAS. This system plays an important role in electrolyte balance. As such, disruption to this system can cause hyperkalemia.

A common risk factor for this condition is diabetes. Osmolality refers to the concentration of dissolved particles in body fluids.

Hyperosmolality describes when fluids have a high osmolality due to high levels of substances such as salt and glucose. Due to factors such as hyperglycemia, people with diabetes may have a high blood osmolality.

As such, people with diabetes may have high levels of potassium in their blood. Both insulin and glucagon are hormones that help regulate blood sugar levels.

They also play a role in helping to regulate potassium levels. As such, having irregular levels of these hormones, such as very low levels of insulin, can impact this regulation and lead to hyperkalemia. Read more about those at higher risk of hyperkalemia. Managing both diabetic nephropathy and hyperkalemia requires a multifaceted approach.

This can include lifestyle changes, medications, and medical monitoring. Some options include:. For some individuals with diabetes, maintaining optimal blood glucose levels through insulin therapy is essential. By improving glucose uptake by cells, insulin can help prevent hyperkalemia.

This works by reducing blood sugar levels and facilitating potassium entry into cells. Insulin therapy can be a treatment option during severe cases of hyperkalemia. Sodium-glucose cotransporter-2 SGLT2 inhibitors are a class of antidiabetic drugs that have shown promise in managing diabetic nephropathy.

Unlike some other drugs, evidence notes that SGLT2 inhibitors can reduce the risk of hyperkalemia. In cases of severe hyperkalemia, a doctor can administer calcium salts. To help with hyperkalemia, a person can administer medications such as albuterol , a beta-2 adrenergic agonist. These medications can shift potassium from the bloodstream into cells, effectively reducing hyperkalemia.

Certain medications known as potassium binders can attach to excess potassium in the gastrointestinal tract. By doing so, they prevent the excess potassium from absorbing into the bloodstream.

Read more about treatment options for diabetic kidney disease. Diabetic nephropathy is a complication of diabetes, while hyperkalemia describes high blood potassium levels.

The two conditions are closely linked. This is due to the impact diabetes can have on kidney function and potassium regulation. Balancing blood sugar levels, addressing kidney function, and managing potassium levels are crucial for individuals with diabetic nephropathy and hyperkalemia.

Treatment options can include insulin, SGLT2 inhibitors, calcium, albuterol, and potassium binders. Diabetic nephropathy is kidney disease that affects people with diabetes. It can cause serious complications, including kidney failure. Early signs…. Symptoms of high potassium, or hyperkalemia, may include nausea, and difficulty breathing.

Kidney issues are the main cause. Learn more here. Why might a doctor suggest a urine protein test? Read on to learn more about this test, including what it measures and what it may indicate.

ACE inhibitors may help prevent diabetic nephropathy in those with type 2 diabetes. They are also the first-line treatment when diabetic nephropathy…. My podcast changed me Can 'biological race' explain disparities in health?

Why Parkinson's research is zooming in on the gut Tools General Health Drugs A-Z Health Hubs Health Tools Find a Doctor BMI Calculators and Charts Blood Pressure Chart: Ranges and Guide Breast Cancer: Self-Examination Guide Sleep Calculator Quizzes RA Myths vs Facts Type 2 Diabetes: Managing Blood Sugar Ankylosing Spondylitis Pain: Fact or Fiction Connect About Medical News Today Who We Are Our Editorial Process Content Integrity Conscious Language Newsletters Sign Up Follow Us.

Medical News Today. Health Conditions Health Products Discover Tools Connect. Diabetic nephropathy and hyperkalemia: Links, risks, and treatment.

PubMed Google Scholar. Laing, S. Mortality from heart disease in a cohort of 23, patients with insulin-treated diabetes.

Diabetologia 46 , — CAS PubMed Google Scholar. He, F. Salt, blood pressure and the renin-angiotensin system. Renin Angiotensin Aldosterone Syst. Adrogué, H. Sodium and potassium in the pathogenesis of hypertension. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.

Elliott, P. INTERSALT Co-operative Research Group. American Diabetes A. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes Diabetes Care.

Google Scholar. Strom, B. Sodium reduction in populations: insights from the Institute of Medicine committee. Jama , 31—32 Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.

BMJ , f Land, M. Salt consumption by Australian adults: a systematic review and meta-analysis. Med J.

Mente, A. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies.

Lancet , — Ekinci, E. High sodium and low potassium intake in patients with Type 2 diabetes. Thomas, M. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 34 , — CAS PubMed PubMed Central Google Scholar.

Dietary salt intake and mortality in patients with type 2 diabetes. PubMed PubMed Central Google Scholar. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.

Tuomilehto, J. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. Horikawa, C.

Dietary sodium intake and incidence of diabetes complications in Japanese patients with type 2 diabetes: analysis of the Japan Diabetes Complications Study JDCS.

Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA , — Graudal, N. Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis.

Committee on the Consequences of Sodium Reduction in P, Food, Nutrition B, Board on Population H, Public Health P, Institute of M.

In: Strom, B. Sodium Intake in Populations: Assessment of Evidence. National Academies Press, Washington DC , Adler, A. Reduced dietary salt for the prevention of cardiovascular disease.

Cochrane Database Syst. Tunstall-Pedoe, H. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study.

BMJ , — Leiba, A. Does dietary recall adequately assess sodium, potassium, and calcium intake in hypertensive patients? Nutrition 21 , — Holbrook, J.

Sodium and potassium intake and balance in adults consuming self-selected diets. Petersen, K. Dietary intake in adults with type 1 and type 2 diabetes: validation of the Dietary Questionnaire for Epidemiological Studies version 2 FFQ against a 3-d weighed food record and h urinalysis.

Villani, A. Sodium intake and excretion in individuals with type 2 diabetes mellitus: a cross-sectional analysis of overweight and obese males and females in Australia. Food label education does not reduce sodium intake in people with type 2 diabetes mellitus.

A randomised controlled trial. Appetite 68 , — Friedewald, W. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Baqar, S. Dietary sodium and potassium intake in people with diabetes: are guidelines being met? Mean yearly urinary sodium excretion of total cohort from - v2 Mean yearly urinary potassium excretion of total cohort from - Adherence to the dietary sodium intake guidelines at an individual level.

Adherence to the dietary potassium intake guidelines at an individual level. Mendis, S. Organizational update: the world health organization global status report on noncommunicable diseases ; one more landmark step in the combat against stroke and vascular disease.

Stroke 46 , e—e National Healthcare Agreement In: Governments CoA, editor. Trevena, H. An evaluation of the effects of the Australian Food and Health Dialogue targets on the sodium content of bread, breakfast cereals and processed meats.

Nutrients 6 , — Webster, J. Salt reduction in Australia: from advocacy to action. Intersalt: an international study of electrolyte excretion and blood pressure.

Results for 24h urinary sodium and potassium excretion. Intersalt Cooperative Research Group. Zhou, B. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late s: the INTERMAP study. CAS Google Scholar. Association of urinary sodium and potassium excretion with blood pressure.

Rodrigues, S. High potassium intake blunts the effect of elevated sodium intake on blood pressure levels. Hypertension: Jash. Daimon, M. Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM.

Biochem Biophys. Anderson, C. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. Dietetic Assoc. Isezuo, S. Salt taste perception and relationship with blood pressure in type 2 diabetics.

Shimazu, T. Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. The development of a national salt reduction strategy for Australia. Asia Pac. Campbell, N.

Int J. Gray, K. Attitudes and beliefs of health risks associated with sodium intake in diabetes. Appetite 83 , 97— Urinary sodium and potassium excretion, mortality, and cardiovascular events.

Yang, Q. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Intern Med. Pfister, R. Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study.

Heart Fail. McCarron, D. The dietary guideline for sodium: should we shake it up? Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.

Diabetes Care 32 , — Download references. was supported by an NHMRC Early Career Research Fellowship , Viertel Clinical Investigatorship, Sir Edward Weary Dunlop Medical Research Foundation grant and RACP fellowship.

was supported by a National Heart Foundation Health Professional Scholarship Department of Endocrinology, Austin Health, Heidelberg, VIC, Australia.

Department of Medicine, The University of Melbourne, Parkville, VIC, Australia. Department of Medicine, Austin Health, Heidelberg, VIC, Australia. You can also search for this author in PubMed Google Scholar. were involved in the study design. and A. were involved in data interpretation. All authors were involved in the editing of the manuscript.

approved the study design and the final content of the manuscript. We thank Dr. Que Lam who assisted with data collection and Professor Leonid Churilov for statistical guidance. Correspondence to Sara Baqar. is an investigator in separate studies sponsored by Novo Nordisk, Bayer, Sanofi and Mobius Medical and E.

The remaining authors have no conflict of interest to declare. Open Access This article is licensed under a Creative Commons Attribution 4.

Reprints and permissions. Dietary sodium and potassium intake in people with diabetes: are guidelines being met?. Diabetes 10 , 23 Download citation. Received : 11 November Revised : 04 May Accepted : 05 May Published : 17 June Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Journal of Radioanalytical and Nuclear Chemistry Skip to main content Thank you for visiting nature.

Download PDF. Subjects Diabetes Nutrition. Abstract Objective Despite public health bodies advocating for lowering dietary sodium and increasing potassium intake to improve cardiovascular outcomes, people with diabetes are not meeting these targets. Methods We conducted this prospective study in a cohort of participants with diabetes who provided h urine collections from to Conclusions People with diabetes do not follow current dietary sodium and potassium guidelines and are less likely to change their dietary intake of sodium and potassium over time.

Introduction Cardiovascular related diseases are the leading cause of morbidity and mortality 1 , especially in those with diabetes 2. Research design and methods Study design and recruitment of participants In this prospective study, we recruited participants with a diagnosis of diabetes from our university teaching hospital diabetes outpatient clinics.

Biochemical urinary and serum analyses Twenty-four-hour urinary sodium uNa , urinary potassium uK , urinary volume uVol , urinary creatinine uCr , urinary urea uUrea , and urinary glucose uGlu were recorded for each urine sample collected by the participants over the seven-year period. Ensuring the accuracy of urine collections Patients attending the diabetes clinics routinely perform h urine collections.

Table 1 Baseline characteristics of study participants. Full size table. Full size image. Table 2 Results of univariate and multivariate analysis. Discussion Key findings Public health bodies advocate for high sodium and low potassium intake to improve cardiovascular health outcomes. Salt appetite, salt taste perception and sodium content in foods may explain variations in sodium intake Overall, people with diabetes may have increased salt appetite and reduced salt taste perception to account for the inability to adhere to low sodium intake.

Is there a range for optimal sodium intake? Strengths and limitations The relatively large sample size of urine collections is considered a major strength. References Appel, L.

PubMed Google Scholar Laing, S. CAS PubMed Google Scholar He, F. CAS PubMed Google Scholar Adrogué, H. PubMed Google Scholar He, F. CAS PubMed Google Scholar Elliott, P. CAS PubMed Google Scholar American Diabetes A.

Thank you for visiting nature. You are using a browser version with limited Potassium and diabetes management managment CSS. To obtain diabetess best experience, we recommend you use managemfnt more ane to date Improving heart health with cholesterol control or turn off compatibility mode in Diaabetes Explorer. Dehydration and allergies the meantime, to Potassium and diabetes management continued support, we are displaying the site without styles and JavaScript. Despite public health bodies advocating for lowering dietary sodium and increasing potassium intake to improve cardiovascular outcomes, people with diabetes are not meeting these targets. We hypothesize that i both at an individual level and within the cohort, there will be a low adherence to the guidelines and ii sodium and potassium intake will remain stable over time. We conducted this prospective study in a cohort of participants with diabetes who provided h urine collections from to